|
1.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2.
|
Park B, Park S, Kim TJ, et al:
Epidemiological characteristics of ovarian cancer in Korea. J
Gynecol Oncol. 21:241–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hashimoto Y, Skacel M and Adams JC: Roles
of fascin in human carcinoma motility and signaling: prospects for
a novel biomarker? Int J Biochem Cell Biol. 37:1787–1804. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Vignjevic D, Kojima S, Aratyn Y, Danciu O,
Svitkina T and Borisy GG: Role of fascin in filopodial protrusion.
J Cell Biol. 174:863–875. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Li A, Dawson JC, Forero-Vargas M, et al:
The actin-bundling protein fascin stabilizes actin in invadopodia
and potentiates protrusive invasion. Curr Biol. 20:339–345. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kureishy N, Sapountzi V, Prag S, Anilkumar
N and Adams JC: Fascins, and their roles in cell structure and
function. Bioessays. 24:350–361. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Pelosi G, Pastorino U, Pasini F, et al:
Independent prognostic value of fascin immunoreactivity in stage I
non-small cell lung cancer. Br J Cancer. 88:537–547. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Zhang H, Xu L, Xiao D, et al: Fascin is a
potential biomarker for early-stage oesophageal squamous cell
carcinoma. J Clin Pathol. 59:958–964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yoder BJ, Tso E, Skacel M, et al: The
expression of fascin, an actin-bundling motility protein,
correlates with hormone receptor-negative breast cancer and a more
aggressive clinical course. Clin Cancer Res. 11:186–192. 2005.
|
|
10.
|
Hashimoto Y, Skacel M, Lavery IC,
Mukherjee AL, Casey G and Adams JC: Prognostic significance of
fascin expression in advanced colorectal cancer: an
immunohistochemical study of colorectal adenomas and
adenocarcinomas. BMC Cancer. 6:2412006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tong GX, Yee H, Chiriboga L, Hernandez O
and Waisman J: Fascin-1 expression in papillary and invasive
urothelial carcinomas of the urinary bladder. Hum Pathol.
36:741–746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kabukcuoglu S, Oner U, Ozalp SS, Bildirici
K, Yalcin OT and Colak E: The role of actin bundling protein fascin
in the progression of ovarian neoplasms. Eur J Gynaecol Oncol.
27:171–176. 2006.PubMed/NCBI
|
|
13.
|
Tao YS, Edwards RA, Tubb B, Wang S, Bryan
J and McCrea PD: beta-catenin associates with the actin-bundling
protein fascin in a noncadherin complex. J Cell Biol.
134:1271–1281. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lee CM, Shvartsman H, Deavers MT, et al:
beta-catenin nuclear localization is associated with grade in
ovarian serous carcinoma. Gynecol Oncol. 88:363–368. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hashimoto Y, Parsons M and Adams JC: Dual
actin-bundling and protein kinase C-binding activities of fascin
regulate carcinoma cell migration downstream of Rac and contribute
to metastasis. Mol Biol Cell. 18:4591–4602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Vignjevic D, Schoumacher M, Gavert N, et
al: Fascin, a novel target of beta-catenin-TCF signaling, is
expressed at the invasive front of human colon cancer. Cancer Res.
67:6844–6853. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hashimoto Y, Ito T, Inoue H, et al:
Prognostic significance of fascin overexpression in human
esophageal squamous cell carcinoma. Clin Cancer Res. 11:2597–2605.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Machesky LM and Li A: Fascin: Invasive
filopodia promoting metastasis. Commun Integr Biol. 3:263–270.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kabukcuoglu S, Ozalp SS, Oner U, et al:
Actin bundling protein fascin expression in ovarian neoplasms:
comparison of histopathologic features of tumors obtained by the
first and secondary cytoreduction surgeries. Eur J Gynaecol Oncol.
27:123–128. 2006.
|
|
20.
|
Cho EY, Choi Y, Chae SW, Sohn JH and Ahn
GH: Immunohistochemical study of the expression of adhesion
molecules in ovarian serous neoplasms. Pathol Int. 56:62–70. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wen YH, Yee H, Goswami S and Shukla PS:
Fascin expression in serous tumors of ovary correlates with
aggressiveness of malignancy. Int J Gynecol Pathol. 28:187–192.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Daponte A, Kostopoulou E, Papandreou CN,
et al: Prognostic significance of fascin expression in advanced
poorly differentiated serous ovarian cancer. Anticancer Res.
28:1905–1910. 2008.PubMed/NCBI
|
|
23.
|
Hashimoto Y, Loftis DW and Adams JC:
Fascin-1 promoter activity is regulated by CREB and the aryl
hydrocarbon receptor in human carcinoma cells. PLoS One.
4:e51302009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Clevers H and Nusse R: Wnt/beta-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Jawhari AU, Buda A, Jenkins M, et al:
Fascin, an actin-bundling protein, modulates colonic epithelial
cell invasiveness and differentiation in vitro. Am J Pathol.
162:69–80. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Gamallo C, Palacios J, Moreno G, Calvo de
Mora J, Suarez A and Armas A: beta-catenin expression pattern in
stage I and II ovarian carcinomas: relationship with beta-catenin
gene mutations, clinicopathological features, and clinical outcome.
Am J Pathol. 155:527–536. 1999. View Article : Google Scholar
|
|
27.
|
Kildal W, Risberg B, Abeler VM, et al:
beta-catenin expression, DNA ploidy and clinicopathological
features in ovarian cancer: a study in 253 patients. Eur J Cancer.
41:1127–1134. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Xie JJ, Xu LY, Zhang HH, et al: Role of
fascin in the proliferation and invasiveness of esophageal
carcinoma cells. Biochem Biophys Res Commun. 337:355–362. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Hu W, McCrea PD, Deavers M, Kavanagh JJ,
Kudelka AP and Verschraegen CF: Increased expression of fascin,
motility associated protein, in cell cultures derived from ovarian
cancer and in borderline and carcinomatous ovarian tumors. Clin Exp
Metastasis. 18:83–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Chen L, Yang S, Jakoncic J, Zhang JJ and
Huang XY: Migrastatin analogues target fascin to block tumour
metastasis. Nature. 464:1062–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
